印/异酸混合物的抗乳腺癌潜力
Ruo Wang1, Renhong Huang1, Yaofeng Yuan2
1Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Archiv der Pharmazie
|August 31, 2023
概括
印/伊萨混合物对乳腺癌 (BC) 具有强烈的抗癌活性,包括耐药类型. 这些化合物为开发新型BC化疗药物提供了有前途的基石.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 乳腺癌 (BC) 是女性癌症死亡的主要原因,其特点是异质性和不良预后.
- 耐药性显著导致BC死亡,突出显示了急需新型化疗药物的迫切需要.
- 印及其类型异素是具有已证明抗癌性能的关键药.
研究的目的:
- 审查英多尔/伊萨混合物的抗乳腺癌 (抗BC) 潜力.
- 探索这些混合物的分子机制和结构-活性关系 (SARs).
- 为了确定BC治疗的潜在新疗法选择.
主要方法:
- 从2020年到现在出版的文章的文献综述.
- 对抗BC.的英多尔/伊萨杂交体的体外和体内研究的分析.
- 对分子标和SARs的评估.
主要成果:
- 印/伊萨混合体对各种BC模型,包括多药耐药菌株,表现出显著的强度.
- 这些混合体表现出极好的选择性,并影响多个与BC相关的生物标.
- 最近的研究强调了它们在临床前环境中的潜力.
结论:
- 印/伊萨混合物代表了一类有前途的化合物,用于开发创新的抗BC化疗药物.
- 了解它们的SAR和分子机制可以指导设计更有效的治疗方法.
- 这些混合物为未来的BC药物发现工作提供了宝贵的基础.
相关概念视频
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
In-situ Hybridization
9.4K
In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
9.4K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


